Clever Culture Systems Limited
CC5
Peringkat dalam Saham
#27506
Based in Adelaide, Australia, Clever Culture Systems Limited, established in... Based in Adelaide, Australia, Clever Culture Systems Limited, established in 2004, focuses on the innovation, development, and market launch of advanced technological solutions for the medical industry. The company operates internationally, serving markets in Australia, the United States, Sweden, the United Kingdom, China, the Netherlands, and Germany. Its core offering is the Automated Plate Assessment System (APAS), which efficiently images, analyzes, and interprets microbiology culture plates, primarily assisting microbiology laboratories and the pharmaceutical manufacturing sector. The company's portfolio also includes Digital Microbiology and specialized APAS modules—artificial intelligence algorithms designed to enable digital reading of culture plates when integrated with the APAS Independence system. Additionally, Clever Culture Systems is advancing its APAS intelligent imaging technology for diverse applications, including urine screening, infection control testing, and assessing antimicrobial susceptibility. Formerly known as LBT Innovations Limited, the company adopted its current name in November 2024.
Harga Saham
$0.0141057
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$30.78M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
32.83%
Negara
AU
Perdagangan Clever Culture Systems Limited (CC5)
Kategori
Healthcare
Laba untuk Clever Culture Systems Limited (CC5)
Laba pada Jun 2024 TTM: $-3.12M
Menurut laporan keuangan terbaru dari Clever Culture Systems Limited, laba saat ini perusahaan adalah $-3.12M. Pada tahun 2023, perusahaan memperoleh laba sebesar $-13.91M, penurunan dibandingkan dengan laba tahun 2022 sebesar $-5.66M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Clever Culture Systems Limited dari 2007 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2026 (TTM) | $-3.12M | 0.00% |
| 2024 | $-3.12M | -77.57% |
| 2023 | $-13.91M | 145.86% |
| 2022 | $-5.66M | 30.43% |
| 2021 | $-4.34M | 11.28% |
| 2020 | $-3.90M | -7.37% |
| 2019 | $-4.21M | 73.60% |
| 2018 | $-2.42M | -67.23% |
| 2017 | $-7.40M | -341.08% |
| 2016 | $3.07M | -1,286.43% |
| 2015 | $-258.70K | -71.75% |
| 2014 | $-915.89K | -370.88% |
| 2013 | $338.11K | -119.00% |
| 2012 | $-1.78M | -10.68% |
| 2011 | $-1.99M | -219.96% |
| 2010 | $1.66M | 689.45% |
| 2009 | $210.37K | -2.53% |
| 2008 | $215.84K | -77.99% |
| 2007 | $980.77K | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $7.61B | -243,863.06% |
US
|
|
| $4.76B | -152,656.14% |
US
|
|
| $-252.70M | 7,995.57% |
US
|
|
| - | - |
CN
|
|
| $1.66B | -53,215.93% |
US
|
